Age-adjusted rates within the G20 for testicular cancer vary from 0.6 to 10.1 per 100,000 over the last five years. The United Kingdom value is 7.1 per 100,000. There are differences in data recording across the world which will at least partly account for the range of values seen.<\/p>
The estimated incidence of testicular cancer in the G20 group in 2018 is published by the International Agency for Research on Cancer Global Cancer Observatory project. This can be viewed at the following link:<\/p>
http://gco.iarc.fr/<\/a><\/p> Data for the European Union, based on the EU 28 countries, is available at the European Cancer Information System at the following link:<\/p> https://ecis.jrc.ec.europa.eu/<\/a><\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"}
}
, "answeringMemberConstituency" : {"_value" : "South Ribble"}
, "answeringMemberPrinted" : {"_value" : "Seema Kennedy"}
, "dateOfAnswer" : {"_value" : "2019-06-27", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-06-27T15:19:33.137Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-06-24", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Testicular Cancer"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, how rates of testicular cancer diagnosis in the UK compare with ratse in other G20 countries over the last five years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1409", "label" : {"_value" : "Biography information for Mr Gregory Campbell"}
}
, "tablingMemberConstituency" : {"_value" : "East Londonderry"}
, "tablingMemberPrinted" : [{"_value" : "Mr Gregory Campbell"}
], "uin" : "268427"}
, {"_about" : "http://data.parliament.uk/resources/1134030", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1134030/answer", "answerText" : {"_value" : " A first progress report covering early implementation of the programme, including numbers of referrals and uptake in its first year, was published as a short report in Diabetic Medicine and is available at the following link:<\/p> https://onlinelibrary.wiley.com/doi/full/10.1111/dme.13562<\/a><\/p> The analyses show that referral numbers and percentage uptake are in excess of prior modelled values. Characteristics of attendees also suggest that the programme is reaching those who are both at greater risk of developing type 2 diabetes and who typically access healthcare less effectively.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"}
}
, "answeringMemberConstituency" : {"_value" : "South Ribble"}
, "answeringMemberPrinted" : {"_value" : "Seema Kennedy"}
, "dateOfAnswer" : {"_value" : "2019-06-27", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-06-27T15:22:24.453Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-06-24", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Diabetes: Preventive Medicine"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment he has made of the effectiveness of the NHS Diabetes Prevention Programme.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1409", "label" : {"_value" : "Biography information for Mr Gregory Campbell"}
}
, "tablingMemberConstituency" : {"_value" : "East Londonderry"}
, "tablingMemberPrinted" : [{"_value" : "Mr Gregory Campbell"}
], "uin" : "268428"}
, {"_about" : "http://data.parliament.uk/resources/1134036", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1134036/answer", "answerText" : {"_value" : " The Government fully understands that maintaining access to all medicines and medical products, including critical medicines and short shelf-life products, is vitally important to millions of people in this country. Ensuring unhindered supply of these products remains the Government\u2019s top priority.<\/p> <\/p> As in preparation for 29 March and 12 April, our \u2018no deal\u2019 EU Exit contingency plans for 31 October will cover the NHS, social care and the independent sector and covers all medicines, medical devices and clinical consumables, supplies for clinical trials, vaccines and countermeasures, and organs and tissues for transplants.<\/p> The Department has continued to work closely with the Devolved Administrations, industry trade bodies and suppliers, the NHS and other key stakeholders. Prior to 29 March, the Department analysed the supply chains of 12,300 medicines, close to half a million product lines of medical devices and clinical consumables, vaccines used in national and local programmes, and essential non-clinical goods on which the health and care system relies. These analyses and assessments have been updated where necessary and will continue to be refined while a \u2018no deal\u2019 EU Exit remains a possibility. This work has informed our plans.<\/p> We are asking suppliers to analyse their supply chains and to make alternative plans if they anticipate disruption, including rerouting to alternative ports or using airfreight where necessary. Our contingency measures aim to support industry-led measures and, where required, act as a \u2018last resort\u2019 to be used only when a supplier\u2019s alternative arrangements encounter difficulties, to ensure uninterrupted supply.<\/p> In the case of medicines that cannot be stockpiled because, for example, they have short shelf-lives, such as medical radioisotopes, we are working closely with suppliers to make alternative arrangements using airfreight.<\/p> Further details can be found at the following link:<\/p> https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans<\/a><\/p> While we never give guarantees, we are confident that, if everyone \u2013 including suppliers, freight companies, international partners and the health and care system \u2013 does what they need to do, the supply of medicines and medical products should be uninterrupted in the event of a no-deal EU Exit.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/1585", "label" : {"_value" : "Biography information for Stephen Hammond"}
}
, "answeringMemberConstituency" : {"_value" : "Wimbledon"}
, "answeringMemberPrinted" : {"_value" : "Stephen Hammond"}
, "dateOfAnswer" : {"_value" : "2019-07-02", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-07-02T11:33:39.527Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-06-24", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "NHS: Drugs"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the availablity of (a) critical and (b) short shelf-life medicines in the event of the UK leaving the EU without a deal.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4614", "label" : {"_value" : "Biography information for Hugh Gaffney"}
}
, "tablingMemberConstituency" : {"_value" : "Coatbridge, Chryston and Bellshill"}
, "tablingMemberPrinted" : [{"_value" : "Hugh Gaffney"}
], "uin" : "268516"}
, {"_about" : "http://data.parliament.uk/resources/1134074", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1134074/answer", "answerText" : {"_value" : " As in preparation for 29 March and 12 April, our contingency plans for 31 October will cover the National Health Service, social care and the independent sector and covers all medicines, medical devices and clinical consumables, supplies for clinical trials, vaccines and countermeasures, and organs and tissues for transplants.<\/p> The Department has continued to work closely with the devolved administrations, industry trade bodies and suppliers, the NHS and other key stakeholders. Prior to 29 March, the Department analysed the supply chains of 12,300 medicines, close to half a million product lines of medical devices and clinical consumables, vaccines used in national and local programmes, and essential non-clinical goods on which the health and care system relies. These analyses and assessments have been updated where necessary and will continue to be refined while a \u2018no deal\u2019 European Union exit remains a possibility. This work has informed our plans.<\/p> We are asking suppliers to analyse their supply chains and to make alternative plans if they anticipate disruption, including rerouting to alternative ports or using airfreight where necessary. Our contingency measures aim to support industry-led measures and, where required, act as a \u2018last resort\u2019 to be used only when a supplier\u2019s alternative arrangements encounter difficulties, to ensure uninterrupted supply.<\/p> While we never give guarantees, we are confident that, if everyone \u2013 including suppliers, freight companies, international partners and the health and care system \u2013 does what they need to do, the supply of medicines and medical products should be uninterrupted in the event of a \u2018no deal\u2019 EU exit.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/1585", "label" : {"_value" : "Biography information for Stephen Hammond"}
}
, "answeringMemberConstituency" : {"_value" : "Wimbledon"}
, "answeringMemberPrinted" : {"_value" : "Stephen Hammond"}
, "dateOfAnswer" : {"_value" : "2019-06-27", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-06-27T15:10:41.92Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-06-24", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Incontinence: Products"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure the continued smooth import and export of continence products and similar medical devices in the event of the UK leaving the EU without a deal; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1538", "label" : {"_value" : "Biography information for Rosie Cooper"}
}
, "tablingMemberConstituency" : {"_value" : "West Lancashire"}
, "tablingMemberPrinted" : [{"_value" : "Rosie Cooper"}
], "uin" : "268443"}
, {"_about" : "http://data.parliament.uk/resources/1134075", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1134075/answer", "answerText" : {"_value" : " NHS Improvement, through an open and competitive procurement process, awarded Deloitte a contract to support NHS Improvement to develop a new NHS Procurement Target Operating Model. The contract for phase 1 of this work, which ended on 31 May 2019, cost £400,000.<\/p> The new Procurement Target Operating Model will consider the processes, data, and skills and capabilities to deliver a more efficient procurement service. The remit of the Procurement Target Operating Model programme does not cover clinical products and therefore were not considered as part of this review. NHS Improvement has collaborated with National Health Service providers\u2019 chief executives, finance and procurement leads to develop the NHS\u2019s procurement target operating model. Members of the Healthcare Supply Association have also been engaged with as part of the target operating model\u2019s development.<\/p> Clinical products, including continence products, which are procured by the NHS are the remit of Supply Chain Coordination Limited who work with NHS providers\u2019 procurement teams across England. Clinical product suppliers have not been engaged with on the new procurement target operating model as they are outside the its remit.<\/p> <\/p> <\/p> <\/p> <\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/1585", "label" : {"_value" : "Biography information for Stephen Hammond"}
}
, "answeringMemberConstituency" : {"_value" : "Wimbledon"}
, "answeringMemberPrinted" : {"_value" : "Stephen Hammond"}
, "dateOfAnswer" : {"_value" : "2019-07-02", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "268445"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-07-02T11:24:10.417Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-06-24", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "NHS: Procurement"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what role has recently been played by Deloitte, and at what cost, in the development by NHS Improvement of proposals to introduce a centralised NHS procurement system for products and services; and what steps are being taken to ensure that the introduction of such a system does not lead to a restriction on the freedom of medical practitioners to prescribe any continence product on the Medicines Tariff that they consider to be the most appropriate product for the individual patient.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1538", "label" : {"_value" : "Biography information for Rosie Cooper"}
}
, "tablingMemberConstituency" : {"_value" : "West Lancashire"}
, "tablingMemberPrinted" : [{"_value" : "Rosie Cooper"}
], "uin" : "268444"}
, {"_about" : "http://data.parliament.uk/resources/1134076", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1134076/answer", "answerText" : {"_value" : " NHS Improvement, through an open and competitive procurement process, awarded Deloitte a contract to support NHS Improvement to develop a new NHS Procurement Target Operating Model. The contract for phase 1 of this work, which ended on 31 May 2019, cost £400,000.<\/p> The new Procurement Target Operating Model will consider the processes, data, and skills and capabilities to deliver a more efficient procurement service. The remit of the Procurement Target Operating Model programme does not cover clinical products and therefore were not considered as part of this review. NHS Improvement has collaborated with National Health Service providers\u2019 chief executives, finance and procurement leads to develop the NHS\u2019s procurement target operating model. Members of the Healthcare Supply Association have also been engaged with as part of the target operating model\u2019s development.<\/p> Clinical products, including continence products, which are procured by the NHS are the remit of Supply Chain Coordination Limited who work with NHS providers\u2019 procurement teams across England. Clinical product suppliers have not been engaged with on the new procurement target operating model as they are outside the its remit.<\/p> <\/p> <\/p> <\/p> <\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/1585", "label" : {"_value" : "Biography information for Stephen Hammond"}
}
, "answeringMemberConstituency" : {"_value" : "Wimbledon"}
, "answeringMemberPrinted" : {"_value" : "Stephen Hammond"}
, "dateOfAnswer" : {"_value" : "2019-07-02", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "268444"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-07-02T11:24:10.467Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-06-24", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Incontinence: Products"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, whether the (a) Health Care Supply Association, (b) main trade associations for suppliers of continence products and (c) organisations representing patients who use continence products have been consulted on the development by NHS Improvement of proposals to introduce a centralised NHS procurement system for products and services.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1538", "label" : {"_value" : "Biography information for Rosie Cooper"}
}
, "tablingMemberConstituency" : {"_value" : "West Lancashire"}
, "tablingMemberPrinted" : [{"_value" : "Rosie Cooper"}
], "uin" : "268445"}
, {"_about" : "http://data.parliament.uk/resources/1134077", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1134077/answer", "answerText" : {"_value" : " I refer the hon. Member to the answer given by the former Parliamentary Under-Secretary of State for Public Health and Primary Care (Steve Brine MP) to the hon. Member for Glasgow Central (Alison Thewliss MP) on 16 January 2019 to Question 206879<\/a>.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"}
}
, "answeringMemberConstituency" : {"_value" : "South Ribble"}
, "answeringMemberPrinted" : {"_value" : "Seema Kennedy"}
, "dateOfAnswer" : {"_value" : "2019-06-27", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-06-27T09:52:01.173Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-06-24", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Preventive Medicine"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, when his Department will publish the Green Paper on prevention.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4389", "label" : {"_value" : "Biography information for Ruth Cadbury"}
}
, "tablingMemberConstituency" : {"_value" : "Brentford and Isleworth"}
, "tablingMemberPrinted" : [{"_value" : "Ruth Cadbury"}
], "uin" : "268534"}
, {"_about" : "http://data.parliament.uk/resources/1134084", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1134084/answer", "answerText" : {"_value" : " In March 2018, NHS England published their policy document \u2018Clinical Commissioning Policy Proposition: Mechanical thrombectomy for acute ischaemic stroke\u2019 which outlines key recommendations for diagnosis, referral, and patient pathways for intervention, and treatment.<\/p> The document can be accessed at the following link:<\/p>